CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-19 | Viret Jean-Frederic Chief Financial Officer | Sale | −100 | $20.81 | $2K | 11,513 |
| 2019-06-19 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,159 | 126,841 | ||
| 2019-06-18 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,000 | $19.31 | $58K | 12,180 |
| 2019-05-31 | Wahlstrom Mats Director | Other disposition | −178,528 | 0 | ||
| 2019-05-31 | Wahlstrom Mats Director | Other acquisition | +98,152 | 318,066 | ||
| 2019-05-30 | Lanfear Dennis M President & CEO | Sale | −32,398 | $19.49 | $631K | 1,284,184 |
| 2019-05-22 | HEALY JAMES Director | Sale | −257,870 | $20.69 | $5.3M | 2,610,351 |
| 2019-03-20 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,000 | $14.92 | $45K | 13,185 |
| 2019-01-11 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-11 | LAWLIS V BRYAN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-11 | Szela Mary T Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-11 | NUSSBAUM SAMUEL R MD Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-11 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-11 | Wahlstrom Mats Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-11 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-11 | Lanfear Dennis M President and CEO | Grant or award | +50,265 | 142,884 | ||
| 2019-01-11 | Lanfear Dennis M President and CEO | Shares withheld for taxes | −17,867 | $12.37 | $221K | 125,017 |
| 2019-01-11 | Lanfear Dennis M President and CEO | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2019-01-11 | Viret Jean-Frederic Chief Financial Officer | Grant or award | +16,685 | 22,482 | ||
| 2019-01-11 | Viret Jean-Frederic Chief Financial Officer | Shares withheld for taxes | −6,297 | $12.37 | $78K | 16,185 |
Page 21 of 39 · 768 trades